glp-1 ibd 🚨 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 Gut Hormones and Inflammatory Bowel

The FDA needs data across different patient populations to feel confident that the drug is both safe and effective broadly, not just in one narrow group

Absorbed pentavalent arsenic is largely reduced to trivalent arsenic in the blood, particularly after low to moderate exposures (Vahter 2002)

Overall Safety and Tolerability Assessment The primary safety conclusion from the comprehensive trial program was unambiguous: AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo

Share this with a colleague who could use a deprescribing refresher

Evidence is lacking on the effects of the many dietary supplements on offer, such as vitamins, flavonoids, plant extracts, and trace elements

The Research History in One Sentence Ipamorelin has established receptor pharmacology and limited human research, but the controlled proof of concept study did not demonstrate significant differences in its main efficacy analyses and did not lead to an identified UK authorisation